Cromos Pharma, where the patients are

CROs/Service Providers

Chiltern partners with Karolinska Development

Thursday, February 13, 2014 01:59 PM

Global CRO Chiltern International has partnered with Karolinska Development, a Sweden-based life science investment company. Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. An exclusive deal flow agreement with Karolinska Institutet Innovations, along with other cooperation agreements with universities, delivers a continuous flow of innovations.

More... »

CRF Health eCOA webinar series

Theorem Clinical Research, Decision Driver Analytics collaborate

Wednesday, February 12, 2014 01:24 PM

CRO Theorem Clinical Research has formed a strategic alliance with Decision Driver Analytics (DDA) to integrate health economics and outcomes research (HEOR), predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.

More... »

Report: global life sciences BPO market to reach $596B globally by 2019

Wednesday, February 5, 2014 01:41 PM

According to a new market report published by Transparency Market Research, a global market intelligence company providing global business information reports and services, the global life sciences BPO market was valued at $152.5 billion in 2012 and is estimated to reach a market value worth $596 billion in 2019, growing at a CAGR of 21.5% from 2013 to 2019.

More... »

Thermo Fisher Scientific completes acquisition of Life Technologies

Wednesday, February 5, 2014 01:15 PM

Thermo Fisher Scientific has completed its acquisition of Life Technologies for $13.6 billion ($76.13 in cash per fully diluted common share), plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.

More... »

inVentiv Health, NeuroVive Pharmaceutical extend partnership

Monday, February 3, 2014 11:44 AM

inVentiv Health, offering best-in-class clinical, commercial and consulting services, has extended its partnership with NeuroVive Pharmaceutical, a publicly-traded Swedish biotech firm specializing in drugs that treat acute cardiovascular and neurological conditions.

More... »

Novotech expands into South Africa

Wednesday, January 29, 2014 01:01 PM

Novotech, an Australia CRO with offices throughout Asia, has expanded its clinical services with a new office in Johannesburg, South Africa, to accommodate increasing sponsor demand for clinical research management.

More... »

GVK BIO to acquire Aragen Bioscience

Wednesday, January 29, 2014 12:58 PM

GVK BIO, an Asia-based CRO, will acquire California-based Aragen Bioscience, a privately-held preclinical CRO specializing in high-value biologics services.

More... »

inVentiv Health, ViS Research partner

Monday, January 27, 2014 01:32 PM

inVentiv Clinical Trial Recruitment Solutions (iCTRS), an inVentiv Health company helping the biopharmaceutical sector reduce time to the start of clinical trials, has announced that the process innovations offered by its partnership with ViS could cut in half the time required to conduct feasibility studies.

More... »

genae opens offices in Frankfurt

Monday, January 27, 2014 01:27 PM

genae, a global CRO and services provider for medical industries, has announced the incorporation of genae Germany in Frankfurt am Main. Frankfurt is a major air, rail and highway transportation hub due to its central location within Germany and Europe. Frankfurt Airport is one of the world's busiest international airports and Frankfurt Central Station is one of the largest terminal stations in Europe.

More... »

Catalent files for IPO

Monday, January 27, 2014 01:26 PM

Catalent, the parent company of Catalent Pharma Solutions, has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of its common stock. The number of shares to be offered and the price range have not yet been determined. The company intends to use the net proceeds from the IPO to repay debt, with any remaining balance to be used for general corporate purposes.

More... »

CenterWatch Data Library



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs